Previous 10 | Next 10 |
NeuroOne Medical Technologies (NMTC) entered into a purchase agreement for the sale of 12.5M shares and warrants to purchase 12.5M shares of its common stock to certain investors in a private placement.Each share of common stock and corresponding warrant is being sold at a purchase price of $...
NeuroOne Medical Technologies Corporation Announces Private Placement PR Newswire EDEN PRAIRIE, Minn. , Jan. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgica...
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer PR Newswire EDEN PRAIRIE, Minn. , Jan. 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; Neur...
NeuroOne® Medical Technologies Corporation Announces First Human Commercial Use of its Evo™ Cortical Electrode at Mayo Clinic EDEN PRAIRIE, Minn. , Dec. 3, 2020 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medic...
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today provides an update on its commercialization plans. Dave Rosa, preside...
Less invasive, more cost-effective solution may enhance neurosurgery for people with neurological brain conditions, including epilepsy NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care optio...
Company Preparing for Commercialization of Thin Film Electrodes Technology NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, tod...
NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the execution of an Exclusive Development and Distribution Agreement with Zimm...
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the appointment of Dr. Camilo Andres Diaz-Botia, a highly experienced...
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the appointment of Vanessa Tolosa to its Scientific Advisory Board. Tol...
News, Short Squeeze, Breakout and More Instantly...
NeuroOne Medical Technologies Corporation Company Name:
NMTC Stock Symbol:
OTCMKTS Market:
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ( ...
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF ™ Ablation System for broader adoption and awareness throughout the healthcare system EDEN ...
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological d...